Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
14.02
-0.04 (-0.32%)
Streaming Delayed Price
Updated: 11:20 AM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Teva Pharmaceutical Industries ADR
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday
August 02, 2023
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Powell Industries, Inc. (NASDAQ: POWL) shares jumped...
Via
Benzinga
Teva Pharma's Stock Soars On Q2 Profit Beat, Highlights Strong Growth From Austedo
August 02, 2023
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) Q2 sales reached $3.88 billion, up 2% Y/Y (4% on constant currency), slightly beating the
Via
Benzinga
Teva Takes A Run At Its 200-Day Line After Second-Quarter Beat And Raise
August 02, 2023
The company also raised the lower boundary of its guidance for full-year sales.
Via
Investor's Business Daily
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
July 26, 2023
The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen
Via
Benzinga
3 Bargain Stocks to Buy on the Dip
June 17, 2023
These stocks should be poised to rebound.
Via
The Motley Fool
Why Teva Pharmaceutical Stock Is Jumping Today
May 18, 2023
Investors are reacting positively to Teva's new growth strategy.
Via
The Motley Fool
Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat Sales
May 10, 2023
Teva reported absolutely flat sales in the first quarter and light earnings.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
July 11, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
July 06, 2023
Via
Benzinga
Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit
July 05, 2023
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale.
Via
Benzinga
Teva Pharmaceutical Clocks Lower Profits On Flat Q1 Sales, Sticks To Annual Guidance
May 10, 2023
Via
Benzinga
Teva Pharmaceutical Indus: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
Geopolitical Risks Prevail
June 27, 2023
A discussion about current geopolitical risks and their impact on commodity and stock markets.
Via
Talk Markets
ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity
June 21, 2023
The supply of an alternative to Adderall, Vyvanse (lisdexamfetamine), a commonly used medication for Attention-deficit/hyperactivity disorder (ADHD), is dwindling, further limiting options for patients...
Via
Benzinga
Drug Shortages in Focus: How FDA's Quest for New Methotrexate Suppliers Affects the Cancer Treatment Landscape
June 12, 2023
The FDA is actively seeking new suppliers to address the shortages of methotrexate, a widely used cancer drug in short supply since March. Methotrexate is an injected medication utilized to treat...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 09, 2023
Via
Benzinga
Is AbbVie or Amgen the Better Bargain Buy Right Now?
June 08, 2023
These elite drugmakers are both working through a number of headwinds.
Via
The Motley Fool
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
June 05, 2023
It's unclear whether the pivot will be enough to halt its recent decline.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
May 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023
May 18, 2023
Via
Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
May 18, 2023
Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).
Via
InvestorPlace
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today?
May 18, 2023
Teva Pharmaceuticals (TEVA) stock is climbing higher on Thursday after the pharmaceutical company announced a new growth strategy.
Via
InvestorPlace
Netflix, Synopsys, Madison Square Garden Entertainment And Other Big Stocks Moving Higher On Thursday
May 18, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session. Urstadt Biddle Properties Inc. (NYSE: UBP) shares surged...
Via
Benzinga
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
May 17, 2023
Benzinga
Via
Benzinga
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
May 17, 2023
AstraZeneca Plc (NASDAQ: AZN) has decided to leave a U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), making it the third company to leave the group in the last...
Via
Benzinga
A Bitter Pill to Swallow: Teva's $235M Challenge to GSK Dismissed by Supreme Court
May 15, 2023
The U.S.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 12, 2023
Via
Benzinga
Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript
May 10, 2023
TEVA earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Nasdaq, S&P 500 Futures Slip Ahead Of Inflation Data — But Analyst Hints It Still Might Be Ok To Be Bullish
May 10, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.